Salicylic Acid
(YGSDEFSMJLZEOE-UHFFFAOYSA-N)
Structure
- SMILES
- OC(=O)c1ccccc1O
- Type(s)
- Approved; Investigational; Vet_approved
- ATC code(s)
- D01AE12; N02BA04; N02BA12; S01BC08
- Molecular Formula:
- C7H6O3
- Molecular Weight:
- 138.121
- Log P:
- 1.0904
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 2
- TPSA:
- 57.53
- CAS Number(s):
- 69-72-7; 8052-31-1; 29656-58-4
Synonym(s)
1.
Salicylic Acid
2.
2-Hydroxybenzoic Acid
3.
o-Hydroxybenzoic Acid
4.
ortho-Hydroxybenzoic Acid
5.
2 Hydroxybenzoic Acid
6.
Acid, 2-Hydroxybenzoic
7.
Acid, Salicylic
8.
Acid, o-Hydroxybenzoic
9.
Acid, ortho-Hydroxybenzoic
10.
o Hydroxybenzoic Acid
11.
ortho Hydroxybenzoic Acid
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 8 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 2 | Toxicity to various agents | FAERS: 8 | US FAERS | |
| 3 | Pain | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Metabolic acidosis | FAERS: 6 | US FAERS | |
| 5 | Mental status changes | FAERS: 5 | US FAERS | |
| 6 | Soft tissue necrosis | FAERS: 5 | US FAERS | |
| 7 | Hypersensitivity | FAERS: 4 | US FAERS | |
| 8 | Musculoskeletal stiffness | FAERS: 3 | US FAERS | |
| 9 | Burning sensation | FAERS: 2 | US FAERS | |
| 10 | Device malfunction | FAERS: 2 | US FAERS | |
| 11 | Immobile | FAERS: 2 | US FAERS | |
| 12 | Oral pain | FAERS: 2 | US FAERS | |
| 13 | Peripheral swelling | FAERS: 2 | US FAERS | |
| 14 | Thermal burn | FAERS: 2 | US FAERS | |
| 15 | Unevaluable event | FAERS: 2 | US FAERS | |
| 16 | Urine ketone body present | FAERS: 2 | US FAERS | |
| 17 | Wrong technique in drug usage process | FAERS: 2 | US FAERS | |
| 18 | Accidental drug intake by child | FAERS: 1 | US FAERS | |
| 19 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 20 | Accidental exposure | FAERS: 1 | US FAERS | |
| 21 | Application site erosion | FAERS: 1 | US FAERS | |
| 22 | Application site erythema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 23 | Application site exfoliation | FAERS: 1 | US FAERS | |
| 24 | Application site hypersensitivity | FAERS: 1 | US FAERS | |
| 25 | Application site reaction | FAERS: 1 | US FAERS | |
| 26 | Application site vesicles | FAERS: 1 | US FAERS | |
| 27 | Arthralgia | FAERS: 1 | US FAERS | |
| 28 | Asthenia | FAERS: 1 | US FAERS | |
| 29 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 30 | Cellulitis | FAERS: 1 | US FAERS | |
| 31 | Completed Suicide | FAERS: 1 | US FAERS | |
| 32 | Crying | FAERS: 1 | US FAERS | |
| 33 | Dehydration | FAERS: 1 | US FAERS | |
| 34 | Diet refusal | FAERS: 1 | US FAERS | |
| 35 | Disorientation | FAERS: 1 | US FAERS | |
| 36 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 37 | Dysphonia | FAERS: 1 | US FAERS | |
| 38 | Erythema | FAERS: 1 | US FAERS | |
| 39 | Expired product administered | FAERS: 1 | US FAERS | |
| 40 | Fatigue | FAERS: 1 | US FAERS | |
| 41 | Headache | FAERS: 1 | US FAERS | |
| 42 | Hyperkeratosis | FAERS: 1 | US FAERS | |
| 43 | Hyperventilation | FAERS: 1 | US FAERS | |
| 44 | Ketonuria | FAERS: 1 | US FAERS | |
| 45 | Oliguria | FAERS: 1 | US FAERS | |
| 46 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 47 | Poisoning | FAERS: 1 | US FAERS | |
| 48 | Pruritus | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 49 | Retching | FAERS: 1 | US FAERS | |
| 50 | Skin hypertrophy | FAERS: 1 | US FAERS | |
| 51 | Skin irritation | FAERS: 1 | US FAERS | |
| 52 | Somnolence | FAERS: 1 | US FAERS | |
| 53 | Swelling | FAERS: 1 | US FAERS | |
| 54 | Tachycardia | FAERS: 1 | US FAERS | |
| 55 | Therapeutic product ineffective | FAERS: 1 | US FAERS | |
| 56 | Thrombosis | FAERS: 1 | US FAERS | |
| 57 | Tinnitus | FAERS: 1 | 18632935 | CTD US FAERS |
| 58 | Vomiting | FAERS: 1 | US FAERS | |
| 59 | nervous system disorder | FAERS: 1 | US FAERS | |
| 60 | Acne | Canada Vigilance: 1 | Canada Vigilance | |
| 61 | Application site discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 62 | Application site necrosis | Canada Vigilance: 1 | Canada Vigilance | |
| 63 | Application site pain | Canada Vigilance: 1 | Canada Vigilance | |
| 64 | Asthma | 6715990 | CTD | |
| 65 | Atherosclerosis | 21601209 | CTD | |
| 66 | Chemical and Drug Induced Liver Injury | 24085192 | CTD | |
| 67 | Chemical burn of skin | Canada Vigilance: 1 | Canada Vigilance | |
| 68 | Hearing Loss | 10418821 | CTD | |
| 69 | Hoarseness | 6715990 | CTD | |
| 70 | Infection | Canada Vigilance: 2 | Canada Vigilance | |
| 71 | Laryngeal Edema | 6715990 | CTD | |
| 72 | Maternal exposure during pregnancy | Canada Vigilance: 1 | Canada Vigilance | |
| 73 | Memory Disorders | 23742082 | CTD | |
| 74 | Nerve injury | Canada Vigilance: 1 | Canada Vigilance | |
| 75 | Neuralgia | Canada Vigilance: 1 | Canada Vigilance | |
| 76 | Nose Diseases | 6715990 | CTD | |
| 77 | Prenatal Injuries | 4502305 | CTD | |
| 78 | Product substitution issue | Canada Vigilance: 1 | Canada Vigilance | |
| 79 | Seizures | 6484774 | CTD | |
| 80 | Skin Papilloma | Canada Vigilance: 1 | Canada Vigilance | |
| 81 | Skin Ulcer | Canada Vigilance: 1 | Canada Vigilance | |
| 82 | Skin neoplasm bleeding | Canada Vigilance: 1 | Canada Vigilance | |
| 83 | Soft Tissue Infection | Canada Vigilance: 1 | Canada Vigilance | |
| 84 | Urticaria | 6715990 | CTD | |
| 85 | Warts | 12852385 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.